triamcinolone acetonide

Adult Dosing .

Dosage forms:  INJ: 40 mg per mL

corticosteroid-responsive conditions

[40-80 mg IM x1]

Start: 60 mg IM x1; Info: dose, frequency varies by condition; use lowest effective dose, shortest effective treatment duration; taper dose gradually to D/C if high-dose or long-term use

allergic conditions

[40-100 mg IM x1]

Info: for hay fever or pollen asthma; use lowest effective dose

multiple sclerosis, acute exacerbation

[160 mg IM qd x1wk, then 64 mg IM qod x1mo]

Info: use lowest effective dose, shortest effective treatment duration; taper dose gradually to D/C

gout, acute

[small joints]

Dose: 2.5-5 mg intra-articularly x1; Max: 10 mg/site up to 80 mg/total dose; Info: use lowest effective dose, shortest effective tx duration; taper dose gradually to D/C if long-term use

[large joints]

Dose: 5-15 mg intra-articularly x1; Max: 40 mg/site up to 80 mg/total dose; Info: use lowest effective dose, shortest effective tx duration; taper dose gradually to D/C if long-term use

rheumatoid arthritis

[small joints]

Dose: 2.5-5 mg intra-articularly x1; Max: 10 mg/site up to 80 mg/total dose; Info: use lowest effective dose, shortest effective tx duration; taper dose gradually to D/C if long-term use

[large joints]

Dose: 5-15 mg intra-articularly x1; Max: 40 mg/site up to 80 mg/total dose; Info: use lowest effective dose, shortest effective tx duration; taper dose gradually to D/C if long-term use

osteoarthritis

[small joints]

Dose: 2.5-5 mg intra-articularly x1; Max: 10 mg/site up to 80 mg/total dose; Info: use lowest effective dose, shortest effective tx duration; taper dose gradually to D/C if long-term use

[large joints]

Dose: 5-15 mg intra-articularly x1; Max: 40 mg/site up to 80 mg/total dose; Info: use lowest effective dose, shortest effective tx duration; taper dose gradually to D/C if long-term use

joint/joint structure inflammation

[small joints]

Dose: 2.5-5 mg intra-articularly x1; Max: 10 mg/site up to 80 mg/total dose; Info: for acute bursitis, acute nonspecific tenosynovitis, epicondylitis, and synovitis; use lowest effective dose, shortest effective tx duration; taper dose gradually to D/C if long-term use

[large joints]

Dose: 5-15 mg intra-articularly x1; Max: 40 mg/site up to 80 mg/total dose; Info: for acute bursitis, acute nonspecific tenosynovitis, epicondylitis, and synovitis; use lowest effective dose, shortest effective tx duration; taper dose gradually to D/C if long-term use

renal dosing

[see below]

renal impairment: not defined, caution advised

HD/PD: not defined, caution advised

hepatic dosing

[not defined]

Peds Dosing .

Dosage forms:  INJ: 40 mg per mL

corticosteroid-responsive conditions

[2 yo and older]

Dose: 0.11-1.6 mg/kg/day IM divided tid-qid; Info: dose, frequency varies by condition; use lowest effective dose, shortest effective treatment duration; taper dose gradually to D/C if high-dose or long-term use

juvenile idiopathic arthritis

[small joints, 2 yo and older]

Dose: 2.5-5 mg intra-articularly x1; Max: 10 mg/site up to 80 mg/total dose; Info: use lowest effective dose, shortest effective tx duration; taper dose gradually to D/C if long-term use

[large joints, 2 yo and older]

Dose: 5-15 mg intra-articularly x1; Max: 40 mg/site up to 80 mg/total dose; Info: use lowest effective dose, shortest effective tx duration; taper dose gradually to D/C if long-term use

joint/joint structure inflammation

[small joints, 2 yo and older]

Dose: 2.5-5 mg intra-articularly x1; Max: 10 mg/site up to 80 mg/total dose; Info: for acute bursitis, acute nonspecific tenosynovitis, epicondylitis, and synovitis; use lowest effective dose, shortest effective tx duration; taper dose gradually to D/C if long-term use

[large joints, 2 yo and older]

Dose: 5-15 mg intra-articularly x1; Max: 40 mg/site up to 80 mg/total dose; Info: for acute bursitis, acute nonspecific tenosynovitis, epicondylitis, and synovitis; use lowest effective dose, shortest effective tx duration; taper dose gradually to D/C if long-term use

renal dosing

[see below]

renal impairment: not defined, caution advised

HD/PD: not defined, caution advised

hepatic dosing

[not defined]